drugset / Trial / NCT02585388
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.
RandomizedParallel-groupOpen-labelTreatment
Summary
The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment
Timeline
- Start
- 2015-10-23
- Primary completion
- 2017-05-15
- Completion
- 2017-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | Oral |
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |
| Background | Vinorelbine | Small molecule | 50 mg | Oral |